SUPPLEMENT Janus kinase inhibitors in autoimmune diseases

and cell subsets as drivers of pathogenesis in different auto-immune diseases. Many of these key cytokines use the Jak/ STAT pathway to exert their effects, rendering them amenable to therapeutic blockade with Jakinibs. Given the apparent pathogenic role of a variety of cytokines like IL-6, IL-12, IL-23, ................
................

In order to avoid copyright disputes, this page is only a partial summary.